Salvage of patients with acute promyelocytic leukaemia with residual disease following ABMT performed in second CR using all-trans retinoic acid

British Journal of Haematology

Volumn 103, Issue 2, 1998, Pages 559-562

  Grimwade, David ^a,d   Jamal, Rahman ^b   Goulden, Nicholas ^c   Kempski, Helena ^c   Mastrangelo, Stefano ^c   Veys, Paul ^c  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

ABMT; APL; ATRA; FISH; MRD monitoring

Indexed keywords

AMSACRINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE DERIVATIVE; DAUNORUBICIN; ETOPOSIDE; MITOXANTRONE; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CASE REPORT; CHILD; DRUG TOLERANCE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; HUMAN; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; NEOPLASM, RESIDUAL; SALVAGE THERAPY; TRETINOIN;

EID: 0031784889     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01008.x     Document Type: Article

References (18)

1. Ding, W., Li, Y.-P., Nobile, L.M., Grills, G., Carrera, I., Paietta, E., Tallman, M.S., Wiernik, P.H. & Gallagher, R.E. (1998) Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARα fusion gene after relapse of acute promyelocytic leukemic from treatment with all-trans retinoic acid and intensive chemotherapy. Blood, 92, 1172- 1183.
2. Diverio, D., Rossi, V., Avvisati, G., De Santis, S., Pistilli, A., Pane, F., Saglio, G., Martinelli, G., Petti, M.C., Santoro, A., Pelicci, P.G., Mandelli, F., Biondi, A. & Lo Coco, F. (1998) Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARα fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter 'AIDA' trial. Blood, 92, 784-789.
3. Fenaux, P., Chomienne, C. & Degos, L. (1997) Acute promyelocytic leukemia: biology and treatment. Seminars in Oncology, 24, 92-102.
4. Frankel, S.R., Eardley, A., Lauwers, G., Weiss, M. & Warrell, R.P. (1992) The 'retinoic acid syndrome' in acute promyelocytic leukemia. Annals of Internal Medicine, 117, 292-296.
5. Grimwade, D., Ilowe, K., Langabeer, S., Burnett, A., Goldstone, A. & Solomon, E. (1996) Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RARα and RARα-PML assessment in patients who ultimately relapse. Leukemia, 10, 61-66.
6. Grimwade, D. & Solomon, E. (1997) Characterisation of the PML/ RARα rearrangement associated with t(15:17) acute promyelocytic leukaemia. Current Topics in Microbiology and Immunology, 220, 81-112.
7. Hann, I.M., Stevens, R.F., Goldstone, A.H., Rees, J.K.H., Wheatley, K., Gray, R.G. & Burnett, A.K. (1997) Randomised comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia: results of the Medical Research Council's 10th AML trial (MRC AML 10). Blood, 89, 2311-2318.
8. Lo Coco, F., Diverio, D., Pandolli, P.P., Biondi, A., Rossi, V., Avvisati, G., Rambaldi, A., Arcese, W., Petti, M.C., Meloni, G., Mandelli, F., Grignani, F., Masera, G., Barbui, T. & Pelicci, P.C. (1992) Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia. Lancet, 340, 1437-1438.
9. Mahmoud, H.H., Hurwitz, C.A., Roberts, W.M., Santana, V.M., Ribeiro, R.C. & Krance, R.A. (1993) Tretinoin toxicity in children with acute promyelocytic leukaemia. Lancet, 342, 1394-1395.
10. Mandelli, F., Diverio, D., Avvisati, G., Luciano, A., Barbui, T., Bernasconi, C., Broccia, G., Ceeri, R., Falda, M., Fioritoni, G., Leoni, F., Liso, V., Petti, M.C., Rodeghiero, F., Saglio, G., Vegna, M.L., Visani, G., Jehn, U., Willemze, R., Muus, P., Pelicci, P.G., Biondi, A. & Lo Coco, F. (1997) Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy, Blood, 90, 1014-1021.
11. Meloni, G., Diverio, D., Vignetti, M., Avvisati, G., Capria, S., Petti, M.C., Mandelli, F. & Lo Coco, F. (1997) Autologous bone-marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RARα fusion gene. Blood, 90, 1321-1325.
12. Román, J., Martín, C., Torres, A., Jiménez, M.A.. Andrés, P., Flores, R., de la Torre, M.J., Sánchez, J., Serrano, J. & Falcón, M. (1997) Absence of detectable PML-RARα fusion transcripts in long-term remission patients after BMT for acute promyelocytic leukemia. Bone Marrow Transplantation, 19, 679-683.
13. Sanz, M.A., de la Rubia, J., Bonanad, S., Barragán. E., Sempere, A., Martín, G., Martínez, J.A., Jiménez, C., Cervera J., Bolufer, P. & Sanz, G.E (1998) Prolonged molecular remission after PML/ RARα-positive autologous peripheral blood stem cell transplantation in acute promyelocytic leukemia: is relevant pretransplant minimal residual disease in the graft? Leukemia, 12, 992-995.
14. 3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood, 89, 3354-3360.
15. Tallman, M.S., Andersen, J.W. Schiffer, C.A., Appelbaum, E.R., Feusner, J.H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C.D., Rowe, J.M. & Wiernik, P.H. (1997) All-trans-retinoic acid in acute promyelocytic leukemia. New England Journal of Medicine, 337, 1021-1028.
16. Tobita, T., Takeshita, A., Kitamura, K., Ohnishi, K., Yanagi, M., Hiraoka, A., Karasuno, T., Takeuchi, M., Miyawaki, S., Ueda, R., Naoe, T. & Ohno, R. (1997) Treatment with a new synthetic retinoid. Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood, 90, 967-973.
17. Van Rhee, F., Lin, F., Cullis, J.O., Spencer, A., Cross, N.C.P. Chase, A., Garicochea, B., Bungey, J., Barrett, J., & Goldman, J.M. (1994) Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood, 83, 3377-3383.
18. Warrell, R.P. (1993) Retinoid resistance in acute promyelocytic leukemia: new mechanisms. strategies and implications. Blood, 82, 1949-1953.